Microsaic Systems plc, the high technology company developing next generation mass spectrometry (MS) instruments, is pleased to announce it has signed an OEM (original equipment manufacturer) supply agreement with GE Healthcare, for the sale of its 4000 MiD® unit in combination with GE Healthcare’s instruments. The agreement, which is the culmination of work done under a previously announced ‘pre-commercial agreement’ (14 April 2014), is centred on the development and commercialisation of an innovative new analytical instrument for use in research and healthcare applications. The two companies are working towards the commercial launch of the integrated product, expected in 2016. Forecast contract volumes are in line with the announcement made on 14 April 2014. The first year of the contract will be extended to the period between the commencement of the contract and 31 December 2016.
Colin Jump, Chief Executive of Microsaic Systems, commenting on the agreement, said:
“We are delighted to sign this agreement with GE Healthcare, one of the foremost players in the global market for scientific instrumentation. Over the last year, teams from both companies have established a close and productive relationship and together we are focused on completing the development of this highly innovative instrument and launching it as soon as possible.”
